Animas® IR 1200, Animas® 2020, One Touch® Ping® Glucose management system, Animas® Vibe™ 를 위한 안전성 경고 / 현장 안전성 서한

Medicines and Healthcare products Regulatory Agency에 따르면, 해당 안전성 경고 / 현장 안전성 서한 는 United Kingdom 에서 manufacturer #17429 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

현장 안전성 서한은 의료기기 제조사 또는 제조사 대리인이 시중에 유통되고 있는 자사 의료기기 제품에 대하여 취할 수 있는 조치를 알리는 소통방식입니다. 주요 대상층은 보건의료업계 종사자와 의료기기 사용자들입니다. 여기에는 회수(recall) 조치와 경고도 포함될 수 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert / Field Safety Notice
  • 사례 ID
    MDA/2012/059
  • 사례 연번
    CON180652
  • 날짜
    2012-08-22
  • 사례 출판 날짜
    2012-08-22
  • 사례 국가
  • 사례 출처
    MHRA
  • 사례 출처 URL
  • 비고 / 경고
    Data from the United Kingdom is current through April 2019. All of the data comes from the Medicines and Healthcare products Regulatory Agency, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and the United Kingdom.
  • 데이터 추가 비고
  • 원인
    Risk of compromised insulin therapy due to failure of the buttons caused by keypad wear. the manufacturer has noted an increase in customer complaints regarding the durability of the insulin pump keypad. deterioration has led to the coating tearing and the edge of the keypad peeling away from the pump. there are also reports of the keys becoming unresponsive or sticking. animas has consequently redesigned the keypad to improve durability. the manufacturer has found that the average time to failure is 18 months. animas distributed a patient notification letter on the 16 july 2012 (see appendix). there is updated information on the animas website (external link).
  • 조치
    Check the list of serial numbers affected in the Animas UK document. Ensure that patients using the pump are aware of: the potential for buttons to fail. the need to examine the keypad regularly for signs of wear, such as peeling or tearing of the keypad edge from the pump. the need to have a back-up insulin delivery method available at all times. Patients and healthcare providers should refer to the updated Animas patient information in the appendix. Patients who identify problems with, or have concerns about, their pump’s keypad should contact their health care provider and Animas customer technical support. Report any problems with the pump to the MHRA. Diabetes departments. Pharmacists. Those involved in procurement, supply and use of this device.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Animas ambulatory insulin infusion pumps. Animas® IR 1200 Animas® 2020 One Touch® Ping® Glucose management system Animas® Vibe™ Devices distributed before February 2012 and which do not contain the revised keypad are affected.
  • Manufacturer

Manufacturer